Ortin Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

8.13

8.13

8.13

16.94

16.94

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

2.73

2.83

3.22

6.88

8.15

Loan funds

Secured loans

6.45

6.14

6.94

19.57

1.81

Unsecured loans

-

-

-

-

14.74

Total

17.31

17.10

18.30

43.39

41.64

Uses of funds

Fixed assets

Gross block

18.78

14.21

14.38

22.45

26.32

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

4.82

-

-

-

5.03

Net block

13.96

14.21

14.38

22.45

21.29

Capital work-in-progress

0.43

0.43

0.43

0.43

0.53

Investments

-

-

-

0.07

0.08

Net current assets

Current assets, loans & advances

6.81

6.07

6.46

93.57

83.18

Less : current liabilities & provisions

3.89

3.60

2.97

73.13

63.44

Total net current assets

2.92

2.46

3.49

20.44

19.74

Miscellaneous expenses not written

-

-

-

-

-

Total

17.31

17.10

18.30

43.39

41.64

Notes:

Book value of unquoted investments

-

-

-

0.07

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

6.00

6.12

Number of equity sharesoutstanding (Lacs)

81.31

81.31

81.31

169.40

169.40